Autoimmune polyendocrinopathy type 3

Autoimmune polyendocrinopathy type 3 (APS-3), also known as autoimmune polyglandular syndrome type 3, is a condition characterized by the co-occurrence of autoimmune thyroid disease (such as Hashimoto's thyroiditis or Graves' disease) with one or more other organ-specific autoimmune disorders, but specifically excluding Addison's disease (adrenal insufficiency) and hypoparathyroidism, which would classify the condition under other autoimmune polyendocrinopathy types. APS-3 is the most common form of autoimmune polyglandular syndrome and primarily affects the endocrine system, though it frequently involves other organ systems as well. The hallmark of APS-3 is autoimmune thyroid disease occurring alongside conditions such as type 1 diabetes mellitus, pernicious anemia, vitiligo, alopecia, celiac disease, or myasthenia gravis. The syndrome is subcategorized based on the associated autoimmune conditions: type 3A involves thyroid disease with other endocrine autoimmunity (e.g., type 1 diabetes), type 3B involves thyroid disease with gastrointestinal autoimmunity (e.g., pernicious anemia, celiac disease), type 3C involves thyroid disease with skin or neuromuscular autoimmunity (e.g., vitiligo, myasthenia gravis), and type 3D involves thyroid disease with connective tissue or other autoimmune disorders. The condition predominantly affects women and typically presents in adulthood. Treatment of APS-3 is directed at managing each individual autoimmune component. Thyroid hormone replacement therapy is used for hypothyroidism, antithyroid medications or radioiodine therapy for hyperthyroidism, insulin for type 1 diabetes, and vitamin B12 supplementation for pernicious anemia. Regular screening for additional autoimmune conditions is recommended, as patients may develop new autoimmune manifestations over time. Genetic susceptibility is linked to specific HLA haplotypes and other immune-regulatory gene variants, and the condition tends to cluster in families, suggesting a multifactorial inheritance pattern with both genetic and environmental contributions.

Common questions about Autoimmune polyendocrinopathy type 3